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mouse Engrailed (En) genes is essential for development of
the midbrain and cerebellum. The regulation of En-2
expression was studied using in vitro protein-DNA binding
assays and in vivo expression analysis in transgenic mice to
gain insight into the genetic events that lead to regional-
ization of the developing brain. A minimum En-2 1.0 kb
enhancer fragment was defined and found to contain
multiple positive and negative regulatory elements that
function in concert to establish the early embryonic mid-
hindbrain expression. Furthermore, the mid-hindbrain
regulatory sequences were shown to be structurally and
functionally conserved in humans. 
The mouse paired-box-containing genes Pax-2, Pax-5
and Pax-8 show overlapping expression with the En genes
in the developing brain. Significantly, two DNA-binding
sites for Pax-2, Pax-5 and Pax-8 proteins were identified in
the 1.0 kb En-2 regulatory sequences, and mutation of the
binding sites disrupted initiation and maintenance of
expression in transgenic mice. These results present strong
molecular evidence that the Pax genes are direct upstream
regulators of En-2 in the genetic cascade controlling mid-
hindbrain development. These mouse studies, taken
together with others in Drosophila and zebrafish on the role
of Pax genes in controlling expression of En family
members, indicate that a Pax-En genetic pathway has been
conserved during evolution.
Key words: En, Pax, mid-hindbrain, development, regionalization,
evolution, enhancer, transgenic mice, lacZ, mouse
SUMMARYINTRODUCTION
Regionalization of the neural tube is an early critical event
during patterning of the central nervous system (CNS) in ver-
tebrates. Over the past decade, a large effort has been directed
toward identifying genes involved in regulating this process.
Many candidate genes display temporally and spatially
restricted expressions that mark different regions of the neural
tube (reviewed in McGinnis and Krumlauf, 1992; Puelles and
Rubenstein, 1993). Recent analysis of mutant phenotypes in
mice has provided direct evidence that such restricted gene
expression is in fact critical for early patterning of the CNS
(reviewed in Joyner and Guillemot, 1994). An important
question that remains from these studies is the nature of the
genetic pathways that regulate early spatially restricted gene
expression and govern regionalization. 
In the developing brain, a number of genes, including
members of the Engrailed (En), Pax and Wnt gene families,
have been shown to be critical for patterning the midbrain and
rostral hindbrain (mesencephalon and metencephalon), which
give rise to the colliculi, tegmentum, isthmus region and cer-
ebellum. The En-1 and En-2 genes, homologues of the
Drosophila segmentation gene engrailed (en), encode homeo-domain-containing transcription factors (Joyner et al., 1985;
reviewed in Joyner, 1996). The Pax gene family consists of
nine members that encode paired domain-containing tran-
scription factors related to Drosophila paired and gooseberry
(reviewed in Gruss and Walther, 1992; Noll, 1993). The Wnt
genes, homologues of the Drosophila segmentation gene
wingless (wg), encode short-range signaling molecules
(reviewed in McMahon, 1992; Nusse and Varmus, 1992). In
mouse embryos, En-1, En-2, Wnt-1, Pax-2, Pax-5 and Pax-8
show spatially and temporally overlapping expression domains
that encompass the developing mid-hindbrain junction region
(Davis et al., 1988; Davis and Joyner, 1988; Adams et al.,
1992; Asano and Gruss, 1992; Püschel et al., 1992; Rowitch
and McMahon, 1995). Expression of all but Pax-8 is initiated
in similar domains shortly following formation of the neural
plate. After neural tube closure, En-1, En-2, Pax-5 and Pax-8
are expressed in broad rings spanning the mid-hindbrain
junction, whereas expression of Wnt-1 and Pax-2 becomes
restricted to a narrower ring near the mid-hindbrain constric-
tion. Expression of these genes in the mid-hindbrain junction
region diverges after 12.5 days post coitum (d.p.c.) as neuro-
genesis proceeds. Similar early overlapping expression
patterns of the En, Pax and Wnt genes in the developing brain
628 D.-L. Song and othershave also been observed in chick, Xenopus and zebrafish
(Davis et al., 1991; Krauss et al., 1991). 
Loss-of-function mutants for En-1, En-2, Wnt-1 and Pax-5
have been generated by gene targeting. En-1 and Wnt-1
homozygous mutants show deletions of the midbrain and cer-
ebellum that can be detected as early as 9.0 d.p.c. (Wurst et al.,
1994; McMahon and Bradley, 1990; Thomas and Capecchi,
1990). En-2 and Pax-5 homozygous mutants have milder phe-
notypes; En-2 mutants show reduction in the size of the cer-
ebellum and an abnormal foliation pattern (Joyner et al., 1991;
Millen et al., 1994), and Pax-5 mutants primarily show a partial
deletion of the inferior colliculus (Urbánek et al., 1994). The
more severe and earlier phenotype of En-1 mutants compared
to that of En-2 mutants was shown to be due to the earlier
expression of En-1 (Hanks et al., 1995). Consistent with this,
En-1/En-2 double mutants have a more severe deletion
phenotype than that of En-1 mutants (W. Wurst and A. L.
Joyner, unpublished data) suggesting that both genes are
required for proper development of this region. By analogy,
the mild Pax-5 mutant phenotype may be due to compensation
by the related Pax-2 and Pax-8 genes. Consistent with this
idea, zebrafish embryos injected with an antibody against
pax[zf-b], the only Pax-5-related protein identified in zebrafish,
show early malformations in the mid-hindbrain junction region
(Krauss et al., 1992). 
Taken together, the early overlapping expression of the En,
Pax and Wnt genes in the mid-hindbrain and the similarity of
mutant brain phenotypes suggests that these genes are part of
a genetic network that controls the development of this region.
Significantly, in Drosophila, a genetic network utilizing homo-
logues of these genes is employed to regulate segmentation,
suggesting that the genetic pathway may have been conserved
through evolution (reviewed in Ingham and Martinez-Arias,
1992; Hooper and Scott, 1992). 
At present, little is known about interactions between these
regulatory genes in the mouse. A study of En expression in
Wnt-1 targeted mutants found that the expression of En genes
was initiated normally but quickly lost (McMahon et al., 1992).
This suggests that Wnt-1 is not required to initiate En
expression but could be involved in the maintenance of En
expression. Alternatively, the loss of En expression in Wnt-1
mutants could reflect the loss of En-expressing cells due to the
absence of a Wnt-1 signal. Due to the early deletion pheno-
types and/or functional overlaps between paralogous genes,
mutant mice have provided limited information regarding
potential gene interactions. Identification of DNA regulatory
sequences and characterization of their interactions with
potential protein regulators are required to directly address this
issue. 
To study the potential interactions between the En, Wnt and
Pax genes in mice, we have analyzed the regulation of En-2
using lacZ reporter constructs in transgenic mice. Previously,
we identified a 9.5 kb En-2 genomic fragment that contains
sufficient regulatory information to direct En-2-like expression
during embryogenesis and in the adult (Logan et al., 1993). A
1.5 kb enhancer fragment was located that is sufficient for at
least the embryonic mid-hindbrain expression. In the present
study, we have further dissected this 1.5 kb enhancer fragment
and found that it contains multiple positive and negative regu-
latory elements that function together to establish the early
embryonic mid-hindbrain expression. A minimum enhancerfragment was used to test whether Pax proteins regulate En-2
expression. Using in vitro electrophoretic mobility shift assays
(EMSA), we identified two DNA-binding sites for Pax-2, Pax-
5 and Pax-8 proteins. Significantly, the Pax-binding sites are
required for initiation and maintenance of the En-2-like early
embryonic expression in transgenic mice. These results present
strong molecular evidence that the Pax genes are the direct




All transgenic constructs were made by inserting mouse and human
En-2 genomic fragments into the SmaI site upstream of phspPT-
lacZpA in a modified pBluescript vector (Kothary et al., 1989; Logan
et al., 1993). The phspPTlacZpA contains promoter sequences (- 664
to +224 relative to the start of transcription) from the mouse hsp68
gene including the translation start site, fused in frame to the lacZ
gene from pMC1871, followed by a 240 bp SV40 polyadenylation
signal. Construct CH/lacZ contains a 1.5 kb ClaI-HindIII fragment
located 6.3 kb upstream of the translation start site (Logan et al. 1993).
The other mouse En-2 genomic fragments cloned in the lacZ reporter
constructs were derived from the CH fragment. Construct CX/lacZ
contains a 1.0 kb ClaI-XbaI fragment. Construct XH/lacZ contains a
500 bp XbaI-HindIII fragment. Construct CA/lacZ contains a 750 bp
ClaI-AccI fragment. Construct (S2X)2/lacZ contains two copies of a
350 bp SstI-XbaI fragment. Constructs CS/lacZ and (CS)2/lacZ
contain one or two copies of a 460 bp ClaI-SstI fragment, respectively.
Constructs S1S2/lacZ and (S1S2)2/lacZ contain one or two copies of a
250 bp SstI-SstI fragment, respectively. Construct D CX/lacZ has the
ClaI-XbaI fragment that contains a 66 bp internal deletion (bp 221-
286 relative to the 5¢ end of the CH fragment). The deleted sequences
include the two Pax-binding sites, BS-I (bp 228-256) and BS-II (bp
257-286). Construct **CX/lacZ has the ClaI-XbaI fragment that
contains point mutations in both Pax-binding sites. Constructs
hEH/lacZ and (hEH)2/lacZ contain one or two copies of a 550 bp
EcoRI-HindIII fragment from the human EN2 locus, which is located
6.8 kb upstream of the translation start site. 
The deletion and site-directed mutagenesis of point mutations in
the D CX and **CX fragments were introduced by polymerase chain
reaction (PCR) (Clackon et al., 1992) using specific primers; D CX:
5¢ -CCCGCATGCACAC-3¢ and 5¢ -GAGGCATGCAAGTTGC-3¢ ;
**CX: 5¢ -GCAGACCCGGGCA-3¢ and 5¢ -CCACTCTTCAGCTGAG-
3¢ . The DNA sequences of the PCR amplified regions were confirmed
by sequencing. 
Production of transgenic mice and analysis of transgene
expression
Outbred CD-1 mice were used to produce transgenic embryos and
mouse lines as described (Hogan et al., 1986). Transgenic embryos
and mice were identified by Southern blot analysis of DNA extracted
from yolk sacs or tail biopsies, using lacZ- or En-2-specific DNA
probes. Transgenic lines were established by breeding founder and/or
generation 1 (G1) males with CD-1 females and subsequently inter-
breeding animals homozygous for the transgene. Transgene
expression patterns were analyzed primarily at 10.5 d.p.c. in genera-
tion 0 (G0) embryos or in transgenic lines from 7.5 d.p.c. to the adult.
The day on which a vaginal plug was observed was designated day
0.5 of gestation. 
Whole-mount lacZ staining and in situ hybridization
b -galactosidase (b -gal) activity was detected in whole-mount
embryos by using X-gal (5-bromo-4-choro-3-indolyl b -D-galacto-
pyranoside) as described (Logan et al., 1993). The embryos were
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tion of mouse and human genomic DNA fragments that direct En-2-
sion. The top diagram shows the mouse En-2 locus in which exons are
xes with coding regions shaded. The enlarged region below represents
entified 1.5 kb ClaI-HindIII enhancer fragment (CH) (Logan et al.,
resent the approximate positions of the Pax-binding sites. The lower
mouse and human En-2 genomic DNA fragments present in the lacZ
ts tested. CX, XH, CA, S2X, CS1 and S1S2 are subfragments derived
ment. hEH is a human genomic fragment derived from the human EN-
t al., 1992). hEH is aligned relative to the CH mouse genomic fragment
ce homology. 2X represents two copies of the DNA fragments
ker lines). All fragments were attached to the hsp68 promoter for
expression. D indicates a 66 bp deletion; *, point mutations; Tg, number
 transgenic embryos analyzed; lacZ, number of transgenics expressing
er of transgenics expressing lacZ in the mid-hindbrain junction region;
atches of expression in the mid-hindbrain junction. b, variability was
ize of the mid-hindbrain junction expression domains. Restriction sites:
 H, HindIII; S1 and S2, SstI; X, XbaI.stained for periods ranging from 30 minutes to overnight according
to the strength of transgene expression. Whole-mount RNA in situ
hybridization of embryos was performed essentially as described
(Conlon and Rossant, 1992). Single-stranded RNA probes labeled
with digoxigenin-UTP were synthesized from linearized template
DNA as directed by the manufacturer (Boehringer Mannheim Bio-
chemicals). The En-2 probe contained a 800 bp BglII-XbaI fragment
within the 3¢ untranslated region; Pax-2, Pax-5 and Pax-8 probes were
as described (Asano and Gruss, 1992).
Sequence analysis
The mouse (1.0 kb) and human (550 bp) enhancer fragments were
restricted into 250-350 bp subfragments and subcloned into the pBlue-
script vector (Strategene, LaJolla, CA). These subclones were sequenced
by the dideoxy chain termination method using the Sequenase DNA
Sequencing Kit (United States Biochemical, Cleveland, OH). All
sequences were analyzed using the University of Wisconsin GCG
sequence analysis program package (Devereux et al., 1984).
DNA-binding assays
EMSA were performed essentially as described previously
(Chalepakis et al., 1991). DNA fragments, synthetic oligonucleotides
of BS-I and BS-II or mutant variants were 3¢ end-
labeled with [32P]dCTP using Klenow polymerase.
The different Pax proteins were expressed under the
control of hCMV promoter/enhancer in transient
transfected COS-7 cells as described (Maulbecker
and Gruss, 1993) and whole cell extracts were used.
The relative binding affinity (Kr) values were
determined by saturation binding experiments as
described previously (Emerson et al., 1985).
RESULTS
Multiple regulatory elements are
required for early embryonic En-2-like
mid-hindbrain expression
To localize the En-2 regulatory elements, we
further dissected the 1.5 kb En-2 genomic
fragment (CH, Fig. 1) that is sufficient to drive
En-2-like brain expression at 10.5-12.5 d.p.c.
(Logan et al., 1993) using a transient transgenic
assay (see Materials and Methods). Initially, two
subfragments of CH, CX (1.0 kb) and XH (500
bp), were tested (Fig. 1). Of eleven 10.5 d.p.c.
transgenic embryos carrying the CX/lacZ
construct, nine showed high levels of b -gal
activity after 30 minutes of X-gal staining in a
broad ring of cells across the mid-hindbrain
junction region (Fig. 2A,B). This expression
pattern is comparable to that directed by the 1.5
kb CH enhancer fragment and to the endogenous
expression pattern of En-2 in the mid-hindbrain.
In contrast, three lacZ-expressing transgenic
embryos carrying XH/lacZ did not result in any
En-2-like transgene expression (data not
shown). As observed previously, all lacZ-
expressing transgenic embryos showed consis-
tent lacZ expression in the spinal cord attribut-
able to the mouse hsp68 promoter (Logan et al.,
1993). In addition, variable ectopic expression
outside the mid-hindbrain junction and spinal
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fragment. 
Two overlapping subfragments of CX, CA (750 bp) and S2X
(350 bp) were then analyzed (Fig. 1). Two copies of S2X failed
to direct any En-2-like expression (data not shown). One copy
of CA retained enhancer activity for directing strong lacZ
expression to the mid-hindbrain junction region (Fig. 2C). Thus,
the enhancer elements were further localized to the CA region.
Interestingly, the CA fragment consistently gave additional low
level lacZ expression throughout the CNS with variable higher
levels in regions of the forebrain and spinal cord. This obser-
vation suggests that the 3¢ region of the CX fragment, not
present in the CA fragment, contains elements that repress
expression outside the mid-hindbrain junction region. 
To further locate the regulatory sequences, two subfrag-
ments, CS1 (460 bp) and S1S2 (240 bp), were analyzed (Fig. 1).
One copy of CS1 gave strong lacZ expression which was
restricted to only the dorsal part of the mid-hindbrain junction
(Fig. 2D,E). Two copies of this subfragment, moreover,
conferred strong and broad expression across the mid-







id-hindbrain expression patterns of lacZ reporter genes directed by
d human En-2 genomic fragments. Lateral (A,C,D,F,G,I) and dorsal
iews of whole-mount 10.5 d.p.c. transgenic embryos stained for b -
ase activity show lacZ expression in the mid-hindbrain junction region
 The different mouse and human En-2 genomic fragments used to
the transgenics are indicated below each photograph (see Fig. 1 for
ns). The lacZ expression in the spinal cord (arrow head) is due to the
moter (Logan et al., 1993). hindbrain junction (Fig. 2F). Two copies, but not one copy, of
S1S2 directed very weak lacZ expression restricted to the dorsal
mid-hindbrain junction, which was detected only after 4 hours
of X-gal staining (Fig. 2G,H). Since CA in one copy gives high
level expression across the mid-hindbrain junction whereas
neither CS1 nor S1S2, in one copy, confers such an expression
pattern, this suggests that enhancer elements located in both
subfragments act cooperatively. Furthermore, the broad
expression domain appears to reflect a higher level of
expression since increasing the copy number of enhancer
elements either by oligomerizing the same element or by
combining different elements resulted in broader expression.
In summary, the 1.0 kb CX subfragment seems to represent
a minimal control region that, in one copy, is capable of recon-
structing En-2-like mid-hindbrain expression. This fragment
appears to contain multiple positive and negative regulatory
elements that act cooperatively to establish a strong and
spatially restricted mid-hindbrain expression pattern
in transgenic embryos.
The 1.0 kb CX fragment functions only as an
early embryonic En-2 mid-hindbrain
enhancer
During embryogenesis, the En-2 gene first shows
spatially defined mid-hindbrain expression and then
gradually becomes restricted to specific groups of
neurons in the midbrain and cerebellum. This
expression pattern was replicated by a lacZ reporter
gene containing 9.5 kb of En-2 genomic DNA (Logan
et al., 1993). We therefore examined the temporal
transgene expression profile directed by the 1.0 kb CX
enhancer fragment at stages from 7.5 d.p.c. to adult in
six transgenic lines carrying CH/lacZ (n=2) and
CX/lacZ (n=4). All the transgenic lines analyzed
showed a similar lacZ expression profile in the devel-
oping brain. b -gal activity was first detected at the 5-
somite stage in two lateral patches of the anterior
neural plate (Fig. 3A). Expression in this region then
expanded to form a ring surrounding the mid-
hindbrain junction (Fig. 3B). The mid-hindbrain
junction expression continued up to 11.5 d.p.c. and
then decreased (data not shown). By 15.5 d.p.c., only
a few lacZ-expressing cells were seen at the junction
of the midbrain and cerebellum (data not shown). No
appreciable lacZ expression was detected in the adult
brain (data not shown). These results demonstrate that
the 1.0 kb CX region contains sufficient regulatory
information for initiating and maintaining early
embryonic En-2 brain expression, but not for later
cell-type-specific expression. 
The early embryonic En-2 mid-hindbrain
regulatory sequences are conserved in the
human EN2 locus
Cross-species homology was used to determine
whether the mid-hindbrain regulatory sequences were
evolutionarily conserved. A human EN2 genomic
clone containing 7.4 kb of sequences upstream of the
coding region was examined by Southern blot analysis
using the mouse 1.0 kb CX fragment as a probe. A 550












hsp68 prothe EN2 coding region was found to hybridize to the mouse 1.0
kb CX fragment (data not shown). Sequence analysis revealed
that the human EN2 fragment had 74% nucleotide identity to
the 5¢ end of the mouse 1.0 kb CX fragment over a 364 bp region
(Fig. 4). We tested whether the human fragment had enhancer
activity in vivo by cloning it into the lacZ reporter construct and
analyzing G0 transgenic embryos for lacZ expression at 10.5
d.p.c. One copy of the human fragment directed strong lacZ
expression to the mid-hindbrain region, although the size of the
expression domain varied from a narrow band to dorsal patches
(data not shown). Moreover, two copies of this human fragment
gave reproducible broad En-2-like expression (Fig. 2I). These
results indicate that the essential En-2 regulatory sequences
required for embryonic En-2 expression have been functionally
conserved in mice and humans, and support the localization of
these sequences to the 5¢ region of the mouse 1.0 kb CX
fragment.





rison of the temporal and spatial patterns of expression for the CX/lacZ
the En-2, Pax-2, Pax-5 and Pax-8 genes. (A,B) Lateral views of
.5 d.p.c. (A) and 9.5 d.p.c. (B) CX/lacZ transgenic embryos stained
dase activity. (C-H) Lateral views of whole-mount 8.5 d.p.c. (C,E,G)
D,F,H) embryos hybridized to Pax-2 (E,F), Pax-5 (C,D), En-2 (G) and
 probes. Arrows indicate mid-hind brain expression.Pax proteins bind to En-2 mid-hindbrain regulatory
elements 
The early mid-hindbrain expression patterns of En-2 and the
CX/lacZ transgene were compared to those of Pax-2, Pax-5 and
Pax-8 to determine whether it is feasible that the Pax genes
regulate En-2 expression. At 8.5 d.p.c. CX/lacZ, En-2, Pax-2 and
Pax-5 shared very similar, if not identical, expression domains
in the anterior neural folds (Fig. 3A,C,E,G). At 9.5 d.p.c. the
CX/lacZ and Pax-5 expression domains were extensively over-
lapping in the mid-hindbrain junction region (Fig. 3B,D),
whereas the Pax-2 domain in this region became restricted to a
narrow ring within the En-2 expression domain (Fig. 3F). Pax-
8 expression was first detected at 9.0 d.p.c. at the mid-hindbrain
junction region (data not shown) and soon expanded caudally to
encompass the En-2 hindbrain expression domain (Fig. 3H). 
To directly address whether Pax proteins regulate En-2
expression, we examined representative members
of each of the four Pax protein subclasses, Pax-1,
Pax-3, Pax-5 and Pax-6 (Walther et al., 1991), by
EMSA for their ability to bind DNA subfragments
derived from the 1.0 kb CX fragment. Pax-1 and
Pax-5 were found to form specific protein-DNA
complexes with sequences located on a 102 bp AluI-
StuI subfragment. Further deletion analysis showed
that two independent Pax-binding sites were present
in this region (data not shown). 
Two putative Pax-binding sequences, BS-I and
BS-II, were defined (Fig. 5A) by comparing the
DNA sequence of the AluI-StuI fragment with
reported Pax-binding sites and their degenerate
consensus sequences (Zannini et al., 1992; Czerny
et al., 1993; Epstein et al., 1994). Each binding site
was shown to bind, with high affinity, to Pax-1 and
members of the Pax-5 subclass (Fig. 5B). The Krs
of BS-I and BS-II to Pax-8 were 3.33· 105 and
0.32· 105, respectively, which are comparable to
the values of other Pax-binding sites (Czerny et al.,
1993). Furthermore, point mutations (Fig. 5A) in
each binding site abolished binding activity to
Pax-8 in EMSA (Fig. 5C). The 550 bp human
fragment was also found to bind to the proteins of
the Pax-5 subfamily (data not shown), and one
putative Pax-binding sequence similar to BS-I was
identified based on sequence analysis.
BS-I and BS-II are required for early
embryonic En-2 mid-hindbrain
expression
The in vivo role of the Pax-binding sites was
tested in 10.5 d.p.c. transgenic embryos by muta-
genesis of these sites within the CX/lacZ
construct. A 66 bp internal deletion that removed
both BS-I and BS-II from the CX fragment (D CX,
Fig. 1) led to a complete loss of En-2-like lacZ
expression in the mid-hindbrain junction region at
10.5 d.p.c. in all lacZ-expressing G0 transgenic
embryos analyzed (Fig. 6D). Point mutations in
both BS-I and BS-II (Fig. 5A) together within CX
(**CX; Fig. 1) consistently resulted in expression
of only weak small dorsal patches (8/8) (Fig. 6E).









and 9.5 d.p.c. (
Pax-8 (H) RNAalone resulted in variable mid-hindbrain expression ranging
from only small patches of dorsal expression (4/13 transgen-
ics) to normal expression (5/13 transgenics) (data not shown).
These results suggest that both Pax-binding sites are critical for
En-2 expression. Four transgenic lines carrying the D CX/lacZ
construct were analyzed to examine the temporal aspect of the
requirement for these Pax-binding sites. No En-2-like
expression was detected in any of the lines from 8.5 (Fig. 6B)
to 12.5 d.p.c. (data not shown). These results demonstrate that
the Pax-binding sites are required for establishing and main-
taining the En-2-like transgene expression in the early
embryonic mouse brain. 
DISCUSSION
We have studied regulation of En-2 expression in transgenic mice
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Fig. 4. Sequence conservation of the mouse and human En-2 DNA
enhancer fragments. Sequence comparison of the mouse (upper line,
CX, bp 244-610) and human enhancer fragments (lower line, hEH, bp
159-532) show 74% identity between the two sequences. Alignment
was performed using BestFit from the GCG package (Devereux et al.,
1984, gap weight: 5.0, length weight: 0.3, average match: 1.0, average
mismatch: - 0.9). GenBank accession no. U41757.
Fig. 5. Binding of Pax proteins to BS-I and BS-II. (A) Top diagram
shows the positions and orientation (arrows) of BS-I and BS-II in the
En-2 locus. Lower panel shows DNA sequence alignments of BS-I
and BS-II with known Pax-2 and Pax-5 recognition consensus
sequences (Czerny et al., 1993; Epstein et al., 1994). The base
matches of both BS-I and BS-II with Pax-2 and Pax-5 recognition
consensus sequences are underlined. Point mutations introduced in
BS-I and BS-II are shown below the wild type sequences.
(B) Binding of Pax proteins to BS-I and BS-II in EMSA. The Pax
proteins analyzed are indicated above each lane. C, refers to control
extracts from cells transfected with the expression vector alone. The
migrating positions for full-length protein-DNA complexes are
indicated (arrow). The faster migrating protein-DNA complexes in
the Pax-2 and Pax-5 lanes likely contain degradation products of the
Pax proteins. F refers to free DNA. (C) Point mutations in BS-I and
BS-II abolish their binding to Pax-8 in EMSA. 
A
B
Cin order to identify genetic events that establish regional diversity
in the developing brain. Our results demonstrate that the dynamic
En-2 expression pattern involves at least two phases of regula-
tion. The initiation and maintenance of the early embryonic
expression in the mid-hindbrain junction region depends on cis-
acting DNA regulatory elements that are located within a
minimum region of 1.0 kb, which have both cooperative positive
and negative effects on transcription. These DNA sequences have
been conserved in humans. Additional and/or different regulatory
elements must be required to direct later En-2 brain expression.
This suggests that multiple trans-acting protein factors partici-
pate in the regulation of En-2 expression throughout develop-
ment. By characterizing the 1.0 kb regulatory sequences both in
vitro and in transgenic mice, we present strong molecular
evidence that one set of critical factors are the Pax proteins, Pax-
2, Pax-5 and Pax-8. These proteins appear to be direct upstream
activators of early En-2 mid-hindbrain expression. 
Multiple DNA regulatory elements are required to
specify En-2 expression in the developing brain 
Our transgenic analysis has defined a 1.0 kb CX fragment as a
minimum control region that is capable of reconstructing En-2-
like transgene expression in the mid-hindbrain junction region
from 8.5 to 11.5 d.p.c. This minimum control region consists of
two enhancer fragments, CS1 and S1S2, and one repressor
fragment, AX. The two positive regulatory fragments appear to
act cooperatively to specify an integrated transgene expression
domain. Each enhancer fragment, CS1 in one copy, or S1S2 in two
copies, is capable of directing specific mid-hindbrain expression
but only to small dorsal patches of cells at the mid-hindbrain
junction. However, the two enhancer fragments together, or CS1
in two copies, act in a synergistic manner to produce a broad ring
of expression across the mid-hindbrain junction. This suggests
that En-2 mid-hindbrain expression in normal embryos depends
on cooperative actions between multiple protein factors interact-
ing with at least two DNA regulatory elements. Biochemicalstudies identified two Pax-binding sites in the CS1 fragment that
are required for En-2-like transgene expression, whereas no Pax-
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more, no apparent DNA sequence similarity was found between
the two enhancer fragments, indicating that they interact with
different trans-acting protein factors. It will be interesting to
further locate other DNA regulatory sequences and to identify the
protein factors that interact with them.
Sequences located within the 3¢ half of the 1.0 kb enhancer
appear to contain DNA-binding sites for a repressor(s), since
deletion of a 3¢ 350 bp AX fragment resulted in a low level of
transgene expression throughout the CNS. Variable higher
levels of expression was also observed in some regions in the
CNS. In normal embryos, En-2 expression is not uniform; it is
strongest at the mid-hindbrain junction and gradually decreases
rostrally and caudally. Chick/quail transplantation experiments
have suggested that the rostral gradient of expression is
mediated by an inhibitory activity emanating from the mesen-
cephalic-diencephalic constriction (reviewed in Alvarado-
Mallart, 1993). Since the additional transgene expression
observed here was throughout the CNS, it is unlikely that the
repressor elements located within the AX fragment are respon-
sible for setting up the normal rostrocaudal expression
gradients. Rather, they may play a role in down regulating En-
2 expression outside the mid-hindbrain junction region. 
Analysis of the developmental expression profile of the 1.0
kb enhancer demonstrated that the transgene contained sufficient
regulatory sequences for initiating En-2-like expression,
however, the expression was not maintained beyond 11.5 d.p.c.
Our previous transgenic analysis showed that a 9.5 kb genomic
fragment is capable of conferring En-2-like expression through-
out development and in the adult (Logan et al., 1993). Based on
these two results, regulation of En-2 brain expression can be
divided into at least two phases: the initiation and early region-
ally restricted expression and later cell-type-specific expression,
which require different cis-acting DNA regulatory elements. The
two phases of En-2 regulation may reflect distinct genetic
programs that control different stages of development of this
region; the early phase corresponding to regional specification
and the late phase to neural differentiation and maturation.
Role of Pax-2, Pax-5 and Pax-8 in regulating early
En-2 mid-hindbrain expression 
The Pax genes can be grouped into four subfamilies (Gruss and
Walther 1992; Walther et al., 1991). The paralogues of each
subfamily share similar genomic organization and protein
structure, and a high degree of sequence identity in the paired
domain. All but Pax-1 exhibit temporally and spatially restricted
expression patterns in the developing CNS, consistent with roles
in regional specification. The developmental importance of Pax
genes in the CNS, as well as in other systems, has been empha-
sized by recent studies of mouse mutants and inherited human
diseases (reviewed in Gruss and Walther, 1992; Chalepakis et
al., 1993; Keller et al., 1994; Sanyanusin et al., 1995). 
Pax proteins act as transcriptional regulators and their
activity has been shown to depend on a specific DNA-binding
activity of the paired domain (Treisman et al., 1991). All of the
previously identified paired domain recognition sequences,
unlike other types of DNA-binding sites, are unusually long
(over 20 bp) and seemingly divergent (Czerny et al., 1993).
Pax-binding sites exhibit a bipartite structure, with each half-
site being represented by a 5¢ and 3¢ consensus motif. Using
EMSA, we identified two DNA-binding sites, BS-I and BS-II,within the 1.0 kb En-2 enhancer fragment for the Pax-5
subfamily proteins and Pax-1. Although BS-I and BS-II share
limited sequence similarity to each other, they both show sig-
nificant base matches with the deduced Pax-binding consensus
sequences in both the 5¢ and 3¢ half-sites. 
Members of the Pax-5 subfamily share over 90% amino acid
identity in their paired domains (Walther et al., 1991). Con-
sistent with this, all three Pax proteins had similar affinities for
BS-I and BS-II. At present, little is known about the molecular
basis of the DNA-binding specificity for different Pax sub-
families. A recent study of the Pax-6 protein has identified
three amino acids in the paired domain that are responsible for
discriminating the DNA-binding sites of Pax-6 versus Pax-5
(Czerny and Busslinger, 1995). Interestingly, Pax-1 and Pax-5
are identical at these three amino acids (Chalepakis et al.,
1991). This may explain why most Pax-5 target sequences,
including BS-I and BS-II, are also recognized by Pax-1. 
The binding specificity of Pax-2, Pax-5 and Pax-8 for BS-I
and BS-II strikingly correlates with the Pax subfamily gene
expression patterns, since only the Pax-5 subfamily shows early
coexpression with En in the developing mid-hindbrain. Intro-
ducing point mutations in the conserved 5¢ or 3¢ core motifs of
BS-I and BS-II abolished the binding to these Pax proteins in
vitro. We demonstrated the functional significance of BS-I and
BS-II in vivo using transgenic mice. Deletion of both DNA-
binding sites from the 1.0 kb enhancer completely abolished
transgene expression in the mid-hindbrain from 8.5 to 12.5
d.p.c., indicating that the Pax-binding sites are essential both for
initiation and maintenance of the early phase of En-2 expression
in normal embryos. Introducing point mutations in both DNA-
binding sites significantly reduced transcription of the transgene;
only weak lacZ-expressing cells were detected in small dorsal
patches at the mid-hindbrain junction. The apparent difference
between the in vitro and transgenic results with point mutations
may suggest that in vivo the Pax protein-DNA complexes are
stabilized by other protein-DNA interactions. 
Comparison of the gene expression pattern of En-2 to that
of Pax-2, Pax-5 and Pax-8 raises questions about the com-
plexity of regulation of En-2 in the brain if these Pax par-
alogues have similar functions, as has been shown for the En
(Hanks et al., 1995) and Hox (Condie and Capecchi, 1994)
genes. For example, Pax-2 expression in the mid-hindbrain is
initiated at least half a day earlier than that of En-2, and Pax-
2 is also expressed in the developing optic cup and otic vesicles
where no En-2 expression has been detected (Davis et al.,
1988; Püschel et al., 1992; Rowitch and McMahon, 1995). This
suggests that activation of En-2 by the Pax proteins may
require co-factors that are only expressed in the mid-hindbrain
junction region from the 5-somite stage, or alternatively that
there are inhibitors that repress En-2 expression at inappropri-
ate times or places during development. Our transgenic
analysis is consistent with both possibilities since it indicates
that the broad domain of En-2-like expression relies on syner-
gistic activation utilizing the Pax-binding site-containing
enhancer fragment and adjacent regulatory sequences as well
as repression of expression outside this region. Finally, since
Pax-2 is expressed prior to and overlapping with En-1 and
Wnt-1, Pax-2 may have a role in initiating En-1 and Wnt-1
expression in the developing brain (Rowitch and McMahon,
1995). Thus, Pax-2, Pax-5 and Pax-8 proteins may have unique
as well as overlapping regulatory roles in brain development.
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Fig. 6. The Pax-binding sites, BS-I and BS-II, are required for transgene expression in the mid-hindbrain junction region. (A-E) Dorsal views
of whole-mount transgenic embryos stained for b -galactosidase activity. (A,C) Transgenic embryos carrying reporter construct CX/lacZ show
an En-2-like mid-hindbrain expression pattern at 8.5 d.p.c. (A) and 10.5 d.p.c. (C) (arrows). (B,D) Transgenic embryos carrying reporter
construct D CX/lacZ which contains a deletion of BS-I and BS-II show no En-2-like lacZ expression in the anterior neural folds at 8.5 d.p.c.
(B, arrow) nor in the mid-hindbrain junction region at 10.5 d.p.c. (D, arrow). (E) A 10.5 d.p.c. transgenic embryo carrying reporter construct
**CX/lacZ which contains point mutations in both BS-I and BS-II. The normal mid-hindbrain lacZ expression pattern is lost, lacZ staining is
only detected in a very small dorsal patch in the mid-hindbrain junction region (arrow). The lacZ staining seen outside the mid-hindbrain
junction region and spinal cord represents ectopic expression (arrowheads).The target-specificity could be accomplished by cooperative
interactions of the Pax proteins with different co-factors. 
Evolutionary conservation of a Pax-En genetic
pathway
Early in Drosophila development, en and wg are expressed in
adjacent stripes that mark the borders between parasegments. This
expression is required for establishment and maintenance of seg-
mentation of the body (reviewed in Ingham and Martinez-Arias,
1992; Hooper and Scott, 1992). The initial en and wg stripes are
set up by overlapping expression of an array of pair-rule genes,
both activators and repressors (DiNardo and O’Farrell, 1987;
DiNardo et al., 1988; Heemskerk et al., 1991; Morrissey et al.,
1991). The paired box-containing gene, paired, is a pair-rule gene
that acts as a positive regulator of en and wg. Following activa-
tion, the expression of en and wg expression in adjacent cells
becomes mutually dependent, mediated by intercellular and intra-
cellular signaling pathways (reviewed in Perimon, 1994). This en-
wg interdependent regulation is only transient as en soon becomes
autoregulated (Heemskerk et al., 1991). 
Based on expression patterns, some of the genetic pathways
involving conserved segmentation genes may have evolved to
control divergent developmental processes in vertebrates. In
this study, using in vitro protein-DNA binding assays and in
vivo expression analysis in transgenic mice, we have provided
strong molecular evidence that Pax-2, Pax-5 and Pax-8 proteins
are directly involved in initiation and maintenance of early En-
2 brain expression. We also showed that the En-2 mid-hindbrain
regulatory sequences are structurally and functionallyconserved in humans. A previous study in zebrafish has
suggested that pax[zf-b], a member of the Pax-5 subclass, was
necessary for normal eng-2 brain expression in fish (Krauss et
al., 1992). Taken together, the studies in Drosophila, zebrafish
and mouse indicate that the Pax-En genetic pathway has been
conserved during evolution. Our identification of cis-regulating
Pax-binding sites for En-2 expression demonstrates the bio-
chemical nature of this interaction in mammals. 
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